Reprocell Inc operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Reprocell Inc with three other
pharmaceutical manufacturers in Asia:
RPG Life Sciences Limited
sales of 3.04 billion Indian Rupees [US$47.15 million]
Taiko Pharmaceutical Company., Limited
(8.29 billion Japanese Yen [US$74.57 million]
Amrutanjan Health Care Limited
based in India
(2.24 billion Indian Rupees [US$34.69 million]
During the year ended March of 2017, sales at
Reprocell Inc were ¥1.26 billion (US$11.31 million).
increase of 18.0%
versus 2016, when the company's sales were ¥1.07 billion.
This was the fifth consecutive year of sales increases at Reprocell Inc
(and since 2012, sales have increased a total of 297%).